Skip to content
mifamurtide
EntityQ411175· pop 10· linked from 51 articles

mifamurtide

Sign in to save

Mifamurtide (trade name Mepact, marketed by Takeda) is a drug against osteosarcoma, a kind of bone cancer mainly affecting children and young adults, which is lethal in over half of cases. The drug was approved in Europe in March 2009.

Key facts

Drug.legal_status
Rx
Drug.Verifiedfields
changed
Drug.Watchedfields
changed
Drug.verifiedrevid
407798436
Drug.IUPAC_name
2-[(N-{(2R)-[(2-acetamido-2,3-dideoxy-D-glucopyranos-3-yl)oxy]-propanoyl}-L-alanyl-D-isoglutaminyl-L-alanyl)amino]ethyl (2R)-2,3-bis(hexadecanoyloxy)propyl hydrogen phosphate
Drug.image
Mifamurtide.svg
Drug.image_class
skin-invert-image
Drug.width
300
Drug.tradename
Mepact
Drug.licence_EU
yes
Drug.pregnancy_category
not investigated
Drug.routes_of_administration
intravenous liposomal infusion over one hour
Drug.bioavailability
N/A
Drug.elimination_half life
minutes (in plasma)18 hrs (terminal)
Drug.CAS_number
83461-56-7
Drug.CAS_supplemental
(mifamurtide sodium)
Drug.ATC_prefix
L03
Drug.ATC_suffix
AX15

via Wikipedia infobox

Wikidata facts

Mass
1236.7485118980003
Show 4 more facts
isomeric SMILES
CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCNC(=O)[C@H](C)NC(=O)CC[C@H](C(=O)N)NC(=O)[C@H](C)NC(=O)[C@@H](C)O[C@H]1[C@@H]([C@H](OC([C@@H]1NC(=O)C)O)CO)O)OC(=O)CCCCCCCCCCCCCCC
canonical SMILES
CCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCNC(=O)C(C)NC(=O)CCC(C(=O)N)NC(=O)C(C)NC(=O)C(C)OC1C(C(OC(C1O)CO)O)NC(=O)C)OC(=O)CCCCCCCCCCCCCCC
chemical formula
C₅₉H₁₀₉N₆O₁₉P
defined daily dose
0.7
Sources (3)

via Wikidata · CC0

~7 min read

Article

10 sections
Contents
  • Medical uses
  • Adverse effects
  • Interactions
  • Pharmacology
  • Mechanism of action
  • Pharmacokinetics
  • Chemistry
  • Synthesis
  • History
  • References

{{Infobox drug | Verifiedfields = changed | Watchedfields = changed | verifiedrevid = 407798436 | IUPAC_name = 2-[(N-{(2R)-[(2-acetamido-2,3-dideoxy-D-glucopyranos-3-yl)oxy]-propanoyl}-L-alanyl-D-isoglutaminyl-L-alanyl)amino]ethyl (2R)-2,3-bis(hexadecanoyloxy)propyl hydrogen phosphate | image = Mifamurtide.svg | image_class = skin-invert-image | width = 300

| tradename = Mepact | licence_EU = yes | pregnancy_AU = | pregnancy_US = | pregnancy_category = not investigated | legal_AU = | legal_CA = | legal_UK = | legal_US = | legal_status = Rx | routes_of_administration = intravenous liposomal infusion over one hour

Gallery (3)

Connections

Categories